News

Early 2020 response to the pandemic was linked to many patients being lost to follow-up, and countries reported worse overall visual acuity among their patients.

New HAWK and HARRIER findings show patients with fluid-free visits reported greater benefit in BVCA while receiving anti-VEGF.

Dr. Califf formerly led the FDA during the Obama Administration.

Investigators also found a high prevalence between OSAS, nasal polyps, nutritional status, and other clinical variables.

Epinephrine before defibrillation was associated with lower odds of survival to discharge, favorable neurological survival, and survival after acute resuscitation

The study used deep phenotyping to identify several factors in adults and adolescents with the disease.

ContagionLive releases their latest e-book on this year's flu season, which includes expert-led opinions and interviews.

Dr. Mustafa speaks on new data related to peanut allergy and Palforzia therapy that were presented at the most recent ACAAI session.

Only 5 individuals of 195 who received liver transplantation had HCC reoccur more than 3 years following surgery.

There has recently been more community spread of C difficile infections.

Patients classified as poor sleepers decreased from 71.4% to 21.4% following the implementation of behavioral sleep intervention treatment.

The interactive map offers patients insights into all available treatments for vitiligo as well as coping strategies.

Various factors decreased the likelihood of achieving SVR, including male gender, cirrhosis, recent injecting drug use, and previous DAA treatment.

There were no serious adverse events or treatment-related adverse events identified in either treatment group.

Fecal microbiota transplantation recipients did gain weight following the procedure.

The treatment cannot be granted full approval due to ongoing litigation.

Year-long treatment with the biologic resulted in significant improvements in patient perception of well-being and treatment effect.

Investigators reported that the medication was safe for patients with moderate-to-severe atopic dermatitis regardless of the presence of allergic comorbidities.

Data show reduction in systolic BP was considered greater than safety concerns related to drugs and interventional treatment, and preference for no intervention over intervention.

Investigators collected data from 5 focus groups of community-based pediatricians to address ongoing concerns on the treatment of atopic dermatitis in this pediatric population.

The randomized control trial investigates the effectiveness of cognitive behavioral therapy in treating chronic pain in patients who have been using opioid therapy.

The adjusted change in 24-hour systolic blood pressure was -11.0 mm Hg in the chlorthalidone group and -0.5 mm Hg in the placebo group.

Data from the LIBERTY AD ADOL trial showed that adolescent patients with moderate-to-severe atopic dermatitis treated with the biologic reported decreases in total and allergen-specific IgE levels for cat dander, peanuts, and more.

Few studies have focused on the psychosocial adjustments of siblings of children with ADHD.

Over half of all patients in the study had achieved an EASI-75 within a year, and investigators noted that patient and family satisfaction with the MADP program was high.

Investigators report that the skin condition mediated the association between a a interleukin-4 receptor agonist variant and food allergy.

Derek Jones talks about how the pandemic will shape healthcare in the coming years.

The FDA has yet to rule on twice-daily pill.